1. Home
  2. MYNZ vs LSBPW Comparison

MYNZ vs LSBPW Comparison

Compare MYNZ & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • LSBPW
  • Stock Information
  • Founded
  • MYNZ 2021
  • LSBPW N/A
  • Country
  • MYNZ Germany
  • LSBPW China
  • Employees
  • MYNZ N/A
  • LSBPW 758
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNZ Health Care
  • LSBPW Health Care
  • Exchange
  • MYNZ Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • MYNZ N/A
  • LSBPW N/A
  • IPO Year
  • MYNZ 2021
  • LSBPW N/A
  • Fundamental
  • Price
  • MYNZ $0.31
  • LSBPW $0.07
  • Analyst Decision
  • MYNZ Buy
  • LSBPW
  • Analyst Count
  • MYNZ 2
  • LSBPW 0
  • Target Price
  • MYNZ $3.00
  • LSBPW N/A
  • AVG Volume (30 Days)
  • MYNZ 2.3M
  • LSBPW N/A
  • Earning Date
  • MYNZ 11-14-2024
  • LSBPW N/A
  • Dividend Yield
  • MYNZ N/A
  • LSBPW N/A
  • EPS Growth
  • MYNZ N/A
  • LSBPW N/A
  • EPS
  • MYNZ N/A
  • LSBPW N/A
  • Revenue
  • MYNZ $917,203.00
  • LSBPW N/A
  • Revenue This Year
  • MYNZ $36.69
  • LSBPW N/A
  • Revenue Next Year
  • MYNZ $91.67
  • LSBPW N/A
  • P/E Ratio
  • MYNZ N/A
  • LSBPW N/A
  • Revenue Growth
  • MYNZ 16.23
  • LSBPW N/A
  • 52 Week Low
  • MYNZ $0.19
  • LSBPW N/A
  • 52 Week High
  • MYNZ $3.39
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 51.63
  • LSBPW N/A
  • Support Level
  • MYNZ $0.28
  • LSBPW N/A
  • Resistance Level
  • MYNZ $0.33
  • LSBPW N/A
  • Average True Range (ATR)
  • MYNZ 0.05
  • LSBPW 0.00
  • MACD
  • MYNZ 0.00
  • LSBPW 0.00
  • Stochastic Oscillator
  • MYNZ 42.69
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: